Literature DB >> 16496309

Multifunctional reversible knockout/reporter system enabling fully functional reconstitution of the AML1/Runx1 locus and rescue of hematopoiesis.

Igor M Samokhvalov1, Andrew M Thomson, Claudia Lalancette, Anna Liakhovitskaia, Janice Ure, Alexander Medvinsky.   

Abstract

Mice deficient in the runt homology domain transcription factor Runx1 die of severe anemia in utero by embryonic day (E)12.5. A reactivatable Runx1 knockout embryonic stem cell (ESC) and mouse systems were generated by the targeted insertion of a loxP-flanked multipartite gene stop/trap cassette designed to simultaneously ablate the expression of Runx1 and report on the activity of its promoters. The cassette's in-frame LacZ reporter enabled activities of the proximal and the distal promoters to be differentially monitored. Although Runx1-null ESCs were capable of primitive erythroid differentiation in vitro, their capacity to generate granulocyte/macrophage or mixed myelo-erythroid embryoid bodies was lost. Cre-mediated reactivation restored Runx1 structural integrity and rescued the hematopoietic differentiation potential of ESCs. Mice with the reactivated allele survived, showed no hematopoietic deficit, and expressed all major splice isoforms of Runx1 appropriately. This multipurpose mouse model will be useful for the analysis of the critical Runx1-dependent check-point(s) in hematopoietic development. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16496309     DOI: 10.1002/gene.20190

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  8 in total

1.  Early ontogenic origin of the hematopoietic stem cell lineage.

Authors:  Yosuke Tanaka; Misato Hayashi; Yasushi Kubota; Hiroki Nagai; Guojun Sheng; Shin-Ichi Nishikawa; Igor M Samokhvalov
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-05       Impact factor: 11.205

Review 2.  Adopting the good reFLEXes when generating conditional alterations in the mouse genome.

Authors:  Frank Schnütgen; Norbert B Ghyselinck
Journal:  Transgenic Res       Date:  2007-04-06       Impact factor: 2.788

3.  Suppression of interneuron programs and maintenance of selected spinal motor neuron fates by the transcription factor AML1/Runx1.

Authors:  Nicolas Stifani; Adriana R O Freitas; Anna Liakhovitskaia; Alexander Medvinsky; Artur Kania; Stefano Stifani
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-21       Impact factor: 11.205

4.  Transcription factors Runx1 to 3 are expressed in the lacrimal gland epithelium and are involved in regulation of gland morphogenesis and regeneration.

Authors:  Dmitry Voronov; Anastasia Gromova; Daren Liu; Driss Zoukhri; Alexander Medvinsky; Robyn Meech; Helen P Makarenkova
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-05-01       Impact factor: 4.799

5.  The transcriptional programme controlled by Runx1 during early embryonic blood development.

Authors:  Yosuke Tanaka; Anagha Joshi; Nicola K Wilson; Sarah Kinston; Shinichi Nishikawa; Berthold Göttgens
Journal:  Dev Biol       Date:  2012-04-21       Impact factor: 3.582

6.  Runx1 is required for progression of CD41+ embryonic precursors into HSCs but not prior to this.

Authors:  Anna Liakhovitskaia; Stanislav Rybtsov; Tom Smith; Antoniana Batsivari; Natalia Rybtsova; Christina Rode; Marella de Bruijn; Frank Buchholz; Sabrina Gordon-Keylock; Suling Zhao; Alexander Medvinsky
Journal:  Development       Date:  2014-09       Impact factor: 6.868

7.  PDGF receptor alpha+ mesoderm contributes to endothelial and hematopoietic cells in mice.

Authors:  Guo Ding; Yosuke Tanaka; Misato Hayashi; Shin-Ichi Nishikawa; Hiroshi Kataoka
Journal:  Dev Dyn       Date:  2013-02-13       Impact factor: 3.780

8.  A new mouse model to study restoration of interleukin-6 (IL-6) expression in a Cre-dependent manner: microglial IL-6 regulation of experimental autoimmune encephalomyelitis.

Authors:  Paula Sanchis; Olaya Fernández-Gayol; Gemma Comes; Kevin Aguilar; Anna Escrig; Mercedes Giralt; Richard D Palmiter; Juan Hidalgo
Journal:  J Neuroinflammation       Date:  2020-10-15       Impact factor: 8.322

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.